Tips to Improve Efficiency and Quality in Pharmaceutical Businesses

Strategy Driven

To remain relevant and record notable growth in the pharmaceutical industry, companies need to make productivity enhancement a priority. well, driving productivity in a pharmaceutical company involves seeking more efficient processes, equipment, and recruitment strategies.

How Has Pharmaceutical Distribution Adapted In Recent Years?

Strategy Driven

In addition to the globalisation of the industry, there has also been a vast amount of technology in pharmaceutical distribution helping to improve the manufacturing process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mgr Business Process Analyst – Teva Pharmaceuticals – Bombay, NY

HR Digest

Mgr Business Process Analyst - Teva Pharmaceuticals - Bombay, NY. The post Mgr Business Process Analyst – Teva Pharmaceuticals – Bombay, NY appeared first on The HR Digest. HR Jobs. The Corporate Systems Analyst is responsible for the successful management of existing core HR systems and related processes end-to-end from understanding. From Adicio - Fri, 08 Feb 2019 13:44:16 GMT - View all Bombay, NY jobs.

Mgr HR Shared Services – 2814 – Teva Pharmaceuticals – Bombay, NY

HR Digest

Mgr HR Shared Services - 2814 - Teva Pharmaceuticals - Bombay, NY. The post Mgr HR Shared Services – 2814 – Teva Pharmaceuticals – Bombay, NY appeared first on The HR Digest. HR Jobs. HR Operations and Services. Associate Director- HR Shared Services. Building relationship with site HR and Business. 8-10 years of work experience in HR Shared. From Adicio - Tue, 05 Feb 2019 19:55:55 GMT - View all Bombay, NY jobs.

The Pharmaceutical Industry Needs a Customer-Centric Digital Transformation - SPONSOR CONTENT FROM INDEGENE

Harvard Business

Sponsor content from Indegene. Innovation Customer service Technology Sponsor Content

Why the Pharmaceutical Industry is Booming in Japan - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Harvard Business

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.

White Coats, Black Scientists

Harvard Business

Race Pharmaceuticals Digital ArticleHow scientific institutions can address systemic racism.

Startup Ideas: 5 Sectors Unaffected By COVID-19

Strategy Driven

Pharmaceuticals. One sector to consider that is both unaffected by COVID-19 and economic recessions is the pharmaceutical industry. When talking about the pharmaceutical industry, there’s not just the production of medicine.

How Medical Nonprofits Set Winning Strategy

Harvard Business

Strategy Research & development Healthcare Pharmaceuticals Technology Digital ArticleA study of nearly 100 organizations.

Adopting AI in Health Care Will Be Slow and Difficult

Harvard Business

Technology Analytics Regulation Healthcare Pharmaceuticals Technology Digital ArticleA few key obstacles and how to overcome them.

Where Telemedicine Falls Short

Harvard Business

Technology Healthcare Pharmaceuticals Digital ArticleIt offers enormous benefits — but can’t replace in-person visits.

It’s Time for a New Kind of Electronic Health Record

Harvard Business

Technology Analytics Healthcare Technology Pharmaceuticals Government Digital ArticleWe need to shift from reactive to preventative care.

The Future of Drug Trials Is Better Data and Continuous Monitoring

Harvard Business

Research & development Technology Pharmaceuticals Healthcare Technology Digital ArticleIt will help patients and bring new treatments to market faster.

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Harvard Business Review

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. Over the last five years, returns for the S&P Pharmaceuticals Select Industry Index have been virtually double that of the S&P 500 (roughly 24% vs. 12% annually). In fact, Congress has explicitly prohibited Medicare from negotiating drug prices with pharmaceutical companies.

Why do some companies achieve exceptional performance while so many others struggle to survive?

First Friday Book Synopsis

Bob''s blog entries Abercrombie & Fitch in retail Better before cheaper: Compete on differentiators other than price Deloitte Heartland Express in trucking Maytag in appliances Merck in the pharmaceutical industry Michael E. In search of an answer that could be supported with empirical proof, Michael E. Raynor and Mumtaz Ahmed, along with their team of researchers at Deloitte, embarked on a daunting quest.

Frank Moss: An interview by Bob Morris

First Friday Book Synopsis

Bob's blog entries (MD) Apollo Computer Baltimore Bluefin Labs Bowstreet Cincinnati Children’s Hospital Frank Moss Haifa IBM Infinity Pharmaceuticals Lotus Development MIT University Princeton University the Mayo Clinic the MIT Media Lab the Practice of New Media Medicine The Sorcerers and Their Apprentices: How the Digital Magicians of the MIT Media Lab Are Creating the Innovative Technologies That Will Transform Our Lives Tivoli Systems Stellar Computer Twitter

Value Migration: A book review by Bob Morris

First Friday Book Synopsis

Value Migration: How to Think Several Moves Ahead of the Competition Adrian J. Slywotzky Harvard Business Press (1995) Note: I recently re-read this book before beginning to formulate questions for an interview of Skywotsky. With all due respect to current business bestsellers, none offers more and better insights of immediate and substantial value. Mastering an [.].

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. The pharmaceuticals industry has seen an explosion in the amount of available data beyond that collected from traditional, tightly controlled clinical trial environments. Analytics Data Research & development Healthcare Pharmaceuticals Digital Article

How Japan Is Creating New Opportunities in the Field of Regenerative Medicine - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Harvard Business

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” It includes a designation system that promotes R&D in Japan aimed at early practical application for innovative pharmaceutical products, medical devices, and regenerative medicines.

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business

In some states, accepting a cup of coffee from a pharmaceutical company must be reported, so “education” over lavish meals or in resort settings has largely receded. Guided by a refreshed ethical framework, pharmaceutical companies, in partnership with researchers and clinicians, can help accelerate the spread of knowledge of new clinical science, which now is notoriously slow. Ethics Research & development Government Healthcare Pharmaceuticals Digital Article

3 Business Models That Could Bring Million-Dollar Cures to Everyone

Harvard Business

Innovation Business models Entrepreneurship Healthcare Pharmaceuticals Technology Digital ArticleTEK IMAGE/SCIENCE PHOTO LIBRARY/Getty Images. When the FDA issued its first approval for a gene therapy for an inherited disease nearly a year ago—a cure for a type of blindness—it was heralded as breakthrough, a moment decades in the making.

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. One place to start might be a fresh look at the incentive compensation structure in the pharmaceutical industry. Sales Marketing Pharmaceuticals Digital Article

Research: Innovation Suffers When Drug Companies Merge

Harvard Business

This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What makes our study unique is that we compared firms’ innovation activities not only before and after acquisitions, but we also compared those merging companies to firms in similar pharmaceutical markets without merger activities. And so pharmaceutical firms appear to be benefitting from regulators’ incomplete decision process.

The Upside of Losing Innovative Employees to Competitors

Harvard Business

A study of pharmaceutical firms finds that it leads to valuable collaborations. Research & development Joint ventures Competition Digital Article

The Competitive Advantage to Creating a Data-Driven Culture

CEO Insider

No matter the industry, whether it is manufacturing, IT, pharmaceuticals, finance, or personal services, companies of all sizes are drowning in data.

What Cancer Researchers Can Learn from Direct-to-Consumer Companies

Harvard Business

Organizations collecting patient data — including academic medical centers, foundations that sponsor cancer research, and pharmaceutical companies — must first identify the needs, pains, hopes, expectations, and behaviors of each person living with cancer. Marketing Research & development Social platforms Non-profit Healthcare Pharmaceuticals Digital Article

Complexity is the New Normal in Healthcare Communications Today

leaderCommunicator

Whether you are a highly matrixed, multisite healthcare system undergoing a merger, or global pharmaceutical or medical device company expanding its portfolio, the common thread is complexity. Even with such rampant murkiness, one thing is very clear: good employee communication can turn strategy into action and keep employees focused on what matters, help them navigate through the change, and minimize disruption that can slow productivity, performance and engagement.

Sexual Harassment Is Rampant in Health Care. Here’s How to Stop It.

Harvard Business

Organizational culture Gender Policy Corporate governance Healthcare Pharmaceuticals Digital ArticleCarmen Martínez Torrón/Getty Images. Many factors make an organization prone to sexual harassment: a hierarchical structure, a male-dominated environment, and a climate that tolerates transgressions — particularly when they are committed by those with power. Medicine has all three of these elements.

A New Approach to Safely Sharing Cancer Patients’ Data

Harvard Business

Shared value Research & development Collaboration Healthcare Pharmaceuticals Digital ArticleIt is well understood that achieving the full potential of precision medicine for all cancer patients depends on the sharing of patients’ genomic and molecular data and clinical information.

Industries That Are Shaping The World We Live In

Strategy Driven

StrategyDriven Editorial Perspective Automotive Industry business management Hi-Tech Medical and Pharmaceutical Industry strategydrivenTo some degree, every single industry is shaping the world we live in. After all, without even the smallest business, the world would be a slightly different place. However, this can be a pedantic way of looking at things.

Leadership Accountability

Great Leadership By Dan

Molinaro has helped create one of the leading brands in the Human Capital industry, working in several key sectors including energy, pharmaceutical, professional services, technology, financial services, and the public sector.

How Pharma Can Offer More than Pills

Harvard Business Review

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. The rationale is simple and elegant: A company with experience selling pharmaceutical products should be able to successfully and profitably sell its large customers (health plans, delivery systems, and governments) other health care offerings.

New Roles Aren’t Cause For Losing Old Skills

thoughtLEADERS, LLC

Ahmed, the Vice President for Manufacturing in a large pharmaceutical company could hardly sit still as frustration boiled over. When leaders take on more responsibility it’s important not to lose all the skills and qualities that got them there. Today’s post is by Graeme Findlay, author of Evolve (CLICK HERE to get your copy).

Shame On Our Apology Economy

Lead Change Blog

Valeant/Philidor pharmaceutical companies. And this list doesn’t include those who really didn’t apologize like Sepp Blatter, former FIFA president; Martin Shkreli, former CEO, Turing Pharmaceuticals; or recently ousted Pennsylvania Attorney General Kathleen Kane). Last week the CEO of Wells Fargo, a bank that’s been around since 1852, testified before Congress about the egregious wrong-doings committed by employees in his company all in the name of meeting sales goals.

What to Do When Your Boss Is the Conflict

Lead from Within

It was from the HR director of a pharmaceutical company, who said, “We have an executive who’s arrogant, angry and forceful all the time and he’s constantly causing conflict—he’s a menace to the organization.”.

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business

The business model of research-based pharmaceutical companies is under significant pressure. However, it also reflects stronger pressures to lower medicine costs in traditional pharmaceutical markets. citizens than pharmaceuticals (the sector’s worst showing in 16 years). And it is the first topic of the provisional standard for the pharmaceutical sector produced by the Sustainability Accounting Standards Board.

The One Meeting that Reliably Produces Huge Consulting Projects

David A Fields

There were about fifteen of us—three from my team and a dozen client personnel—in a conference room at the headquarters of one of the world’s largest pharmaceutical companies. The meeting was long. Lively, but grueling. It took an investment of time and even a bit of cash to pull together. (I I brought two, contract consultants in to prep and attend the meeting.)

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. ” By selling a drug they’re already making under a different name, pharmaceutical firms are effectively extending their monopoly for another six months. Another way pharmaceutical firms are thwarting generics is by restricting access to samples for testing. Regulation Branding Manufacturing Pharmaceuticals Digital Article

Price Gouging and the Dangerous New Breed of Pharma Companies

Harvard Business

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development. Ionis Pharmaceutical has been especially successful in creating a pipeline of these drugs, such as Nusinersen, a promising therapy for spinal muscular atrophy.

Price 44

Lisa Petrilli: The Character-Based Leader Co-Author Interview

Lead Change Blog

COO and CMO, To Be a Woman CRO (Chief Relationship Officer), CEO ConnectionLisa Petrilli's corporate leadership experience includes running a $750 million medication delivery business and a team of marketers while negotiating global licensing, commercialization and co-marketing contracts with pharmaceutical companies.

COO 253

Is GSK taking the Sales out of Sales Rep?

LDRLB

It’s been over half a year since a potentially landmark event occurred in the pharmaceutical industry. I spent five years in the pharmaceutical industry, and had the chance to talk to many GSK representatives when the measures were announced. Most believed it was just a public relations stunt to try and present themselves as the “good guys” in pharmaceutical marketing – focused solely on customer needs.

Debating the Sackler Family Role in the Opioid Crisis, and Using AI Bots to Conduct Job Interviews

Harvard Business

Youngme, Felix, and Mihir discuss whether pharmaceutical players like the Sackler family members should be held accountable for the current opioid crisis. They then debate the growing reliance on artificial intelligence bots by human resource departments in the job screening process. Social responsibility Economics & Society Technology Audio

Clive Wilson on how to design a purposeful organisation: Part 1 of an interview by Bob Morris

First Friday Book Synopsis

Primeast works primarily in the oil and gas, power, pharmaceutical and […]. Clive Wilson is a writer, speaker, facilitator and business coach. He is a director of Primeast, a learning and development company based in the beautiful town of Harrogate in the county of North Yorkshire in the United Kingdom, some 220 miles north of London.